Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 35,000,000
    Countries
    Sector(s)
    Spain : € 35,000,000
    Industry : € 35,000,000
    Signature date(s)
    30/12/2024 : € 35,000,000

    Summary sheet

    Release date
    6 June 2024
    Status
    Reference
    Signed | 30/12/2024
    20230807
    Project name
    Promoter - financial intermediary
    GREENLIGHT BIO (IEU G)
    GREENLIGHT BIOSCIENCES ESPANA SLU
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 35 million
    EUR 75 million
    Location
    Sector(s)
    Description
    Objectives

    The project concerns the research & development, registration, commercialisation and manufacturing of a pipeline of Ribonucleic acid interference (RNAi)-based and other biocontrol solutions for plant health and bee health, addressing challenges for farmers and crop protection such as resistance and residues within the EU or benefitting the EU to be launched between 2024 and 2027.

    The project could address three main challenges for the farmers and crop protection: resistance, residues and regulation. The promoter proposes an innovative and disruptive formula for agricultural crop protection with reduced soil persistence and may contribute to reducing application or displacing chemicals pesticides classified by the EU as candidates for substitution. It aligns with the EU Green Deal objectives, notably concerning biodiversity and farm-to-fork strategies and targets reducing the use and risk of chemical pesticides, as well as the use of the more hazardous pesticides, by 50% by 2030.

    Additionality and Impact

    The project is in line with the InvestEU objective of the RIDW Schedule A.1.2 of the EIB InvestEU Guarantee Agreement and the eligible policy area described in article 5 heading 1.5 Bioeconomy. The operation contributes to the InvestEU objective of research, development, and innovation. The purpose of the loan is to provide direct, equity-type financing under the EIB's Venture Debt Instrument to support research, development, and innovation (RDI) activities of an innovative Spanish agritech company focused on developing high performance new plant protection solutions with reduced environmental and toxicological impact. The financing of this project addresses the failure in financial markets for RDI, arising from limited access to commensurate financing due to factors such as information asymmetries, misalignment of incentives, etc. By creating knowledge externalities, the project is expected to provide significant socio-economic benefits, strengthen Spain and Europe's position in the field of sustainable food production, and help create and retain skilled staff in a cohesion area, thus fostering regional development. Thanks to the support of InvestEU, the EIB may provide long-term financing in the form of venture debt to a highly innovative company with no access to commercial debt. By contributing to extending the cash runway and, therefore, de-risking the development plan of the company, the EIB financing is expected to attract third-party investors and accelerate the company's development. The project would not have been carried out (to the same extent) by the EIB without the support of InvestEU.

    Environmental aspects
    Procurement

    The promoter's investments concern research, development and innovation activities that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2014/52/EU (amending 2011/92/EU). Full environmental details verified during appraisal.

    The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus, it is not covered by EU Directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The EIB will verify details during the project due diligence.

    Milestone
    Under appraisal
    Approved
    Signed
    20 December 2024
    30 December 2024
    Related projects

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - GREENLIGHT BIO (IEU G)
    Publication Date
    3 Jan 2025
    Document language
    Main Topic
    Lending
    Document Number
    216898984
    Document Focus
    Environmental Information
    Project Number
    20230807
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications